Clinical Trial Update: Clinical Study of Fulvestrant Combined With Chidamide in the Treatment of Hormone Receptor-positive Advanced Breast Cancer Resistant to CDK4/6 Inhibitors [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating fulvestrant in combination with chidamide for hormone receptor-positive advanced breast cancer resistant to CDK4/6 inhibitor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Chidamide (chidamide)
• Fulvestrant (fulvestrant)

Snippet

Sponsor: Liaoning Cancer Hospital & Institute | Conditions: Breast Cancer | Phase 4 | Status: UNKNOWN